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ERKWehave recently found that themembrane-associated guanylate kinasewith inverted organization-1 (MAGI-1)
was enriched in rat nervous tissues such as the glomeruli in olfactory bulb of adult rats and dorsal root entry zone
in spinal cord of embryonic rats. In addition, we revealed the localization of MAGI-1 in the growth cone of the
primary cultured rat dorsal root ganglion cells. These results point out the possibility that MAGI-1 is involved
in the regulation of neurite extension or guidance. In this study, we attempted to reveal the physiological
role(s) of MAGI-1 in neurite extension. We found that RNA interference (RNAi)-mediated knockdown of
MAGI-1 caused inhibition of nerve growth factor (NGF)-induced neurite outgrowth in PC12 rat pheochromocy-
toma cells. To clarify the involvement of MAGI-1 in NGF-mediated signal pathway, we tried to identify binding
partners for MAGI-1 and identiﬁed p75 neurotrophin receptor (p75NTR), a low afﬁnity NGF receptor, and Shc,
a phosphotyrosine-binding adaptor. These three proteins formed an immunocomplex in PC12 cells. Knockdown
as well as overexpression of MAGI-1 caused suppression of NGF-stimulated activation of the Shc-ERK pathway,
which is supposed to play important roles in neurite outgrowth of PC12 cells. These results indicate that MAGI-1
may act as a scaffolding molecule for NGF receptor-mediated signaling pathway.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The membrane-associated guanylate kinase with inverted organiza-
tion (MAGI) proteins belong to a subfamily of membrane-associated
guanylate kinase (MAGUK) proteins, and consist of three members,
MAGI-1, MAGI-2/synaptic scaffolding molecule (S-SCAM) and MAGI-3.
They usually harbor six PSD-95/Discs Large/Zona Occludens (PDZ) do-
mains, a GUK domain and two WW motifs [1–3]. MAGI-2/S-SCAM is
the neural isoform of MAGI protein and interacts with various synaptic
molecules such as NMDA receptors, neuroligins and AMPA receptors
[2,4,5]. Physiological functions ofMAGI-1 have been investigatedmainly
in non-neuronal tissues; it is localized at tight junction of epithelial
cells [6] and cell–cell contacts of vascular endothelial cells [7]. Although
MAGI-1 is thought to act as a scaffold for various proteins such as
β-catenin, RapGEP and JAM4 at non-neuronal cell junctions [8–10], theembrane-associated guanylate
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l rights reserved.physiological signiﬁcance of MAGI-1 in neuronal tissues is yet obscure.
We have recently developed the speciﬁc antibody for MAGI-1 and
found that MAGI-1 was enriched in rat neural tissues such as the glo-
meruli in olfactory bulb of adult rats and dorsal root entry zone in spinal
cord of embryonic rats. In addition, we found the localization of MAGI-1
in the growth cone of primary cultured rat dorsal root ganglion neurons
[11]. These results appeared to indicate the possible participation of
MAGI-1 in neurite extension or guidance.
Neurotrophins are a family of proteins that inﬂuence various activities
of neuronal cells such as proliferation, growth and differentiation [12,13].
They interact with two distinct classes of receptors, tropomyosin-related
kinase (Trk) family consisting of TrkA, TrkB and TrkC, and p75 neuro-
trophin receptor (p75NTR). Four neurotrophins, NGF, BDNF, NT-3 and
NT-4, exhibit speciﬁcity for Trk receptors, and NGF interacts only with
TrkA [14]. The cytoplasmic domain of Trk can interact with various
molecules involved in signaling cascade such as Ras-extracellular
signal-regulated kinase (ERK), phosphatidylinositol-3 (PI3) kinase and
phopholipase C (PLC)-γ1 signaling. In PC12 rat pheochromocytoma
cells, NGF binds to TrkA with high afﬁnity and induces Ras-mediated
activation of ERK that leads to subsequent proliferation and differentia-
tion [12]. On the other hand, p75NTR does not possess a cytoplasmic
tyrosine kinase domain and interacts with Trk receptors. As a Trk co-
receptors p75NTR binds each of neurotrophinswith relatively low afﬁn-
ity [15], and has been shown to enhance Trk receptor activity mediated
by neurotrophins [16,17].While p75NTR does not have intrinsic catalyt-
ic activity, this protein interacts with diverse signaling molecules such
as tumor necrosis factor receptor-associated factor-6 (TRAF6), RhoA
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apoptosis, cell survival and neurite outgrowth [18–20].
Here,we demonstrate thatMAGI-1 regulatesNGF-stimulated neurite
extension of PC12 cells. Moreover we found that MAGI-1 interacts with
p75NTR and Shc, and acts as a scaffolding molecule for NGF signaling
pathway.
2. Materials and methods
2.1. Plasmid construction
pRK5-myc-mouse MAGI-1 was obtained from Dr. K. Patrie (Univer-
sity of Michigan). Mouse MAGI-2 and MAGI-3 were from Drs. Y. Hata
(Tokyo Medical and Dental University, Japan) and E. Peles (The Weiz-
mann Institute of Science, Israel), respectively. Full length and various
fragments of MAGI proteins, p75NTR and Shc were produced by PCR
and subcloned into pCAG-GFP-MCS2, pCAG-myc-MCS2, pCAG-FLAG-
MCS2 [21], EGFP-C1(Clontech Laboratories, Inc., CA, USA), pMal (New
England Biolab. Inc., MA) and pGEX-4T3 (GE Healthcare Bio-Sciences,
Uppsala, Sweden) vectors. All constructs were veriﬁed with DNA se-
quencing. GFP-ERK was obtained from Dr. N. Kioka (Kyoto University,
Japan).
2.2. Antibodies and reagents
Using glutathione S-transferase (GST)-fused p75NTR fragment (p75-
intracellular domain, aa 274–472) expressed in Escherichia coli as an an-
tigen, a rabbit polyclonal antibody for p75NTR, anti-p75, was generated
and afﬁnity-puriﬁed on a column to which the antigen had been conju-
gated. A MAGI-1-speciﬁc antibody, anti-MAGI-1, and pan-MAGI anti-
body, anti-MAGI1/2/3, were prepared as described previously [11].
Polyclonal rabbit anti-phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr/
204), anti-Shc, anti-phospho Shc (Tyr239/240) (Cell Signaling Technol-
ogy Inc., Danvers, MA, USA), and anti-GFP (Medical & Biological Labora-
tories Co., Nagoya, Japan)were purchased. Ratmonoclonal anti-GFPwas
obtained from Nacalai Tesque (Kyoto, Japan). Monoclonal mouse anti-
p75NTR (clone 192-IgG, Millipore), anti-GFP (Santa Cruz Biotech. Inc.,
Santa Cruz, CA, USA) and anti-myc 9E10 [22] were also used.
2.3. Cell culture and transfection
COS7 cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and antibi-
otics. PC12 cells were cultured in DMEM supplemented with 10% horse
serum, 5% FBS and antibiotics. Transient transfection was carried out
with the Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
2.4. Immunoﬂuorescent analysis
Immunoﬂuorescent analysiswas done as described [23]. Alexa Fluor®
488 and 568 (Invitrogen)were used as secondary antibodies. Fluorescent
images were obtained using FV-1000 confocal microscope (Olympus
Corporation, Tokyo, Japan).
2.5. RNA interference
The following target sequences were inserted to pSUPER-puro or
pSUPER-GFP vector (OligoEngine, Seattle, WA, USA), rat MAGI-1; 5′-
GTCGGCACCTATGAAGGAA-3′ (534–552, MAGI#1), 5′-AGTGATCACGAC
GGATGCC-3′ (599–617, MAGI#2). Numbers indicate positions from
transcription start sites. We usually used pSUPER-puro vector for bio-
chemical analysis and pSUPER-GFP vector for cell biological analysis.
To generate RNAi-resistant mutants of MAGI-1, MAGI-1#1mt and
MAGI-1#2mt, we introduced three silent mutations, as underlined,
in the target sequences of pSUPER-MAGI-1#1 (5′-GTCGGGACCTACGAG
GGAA-3′) and pSUPER-MAGI-1#2 (5′-AGTCATCACCACCGATGCC-3′).2.6. Quantiﬁcation of neurite-bearing cells
PC12 cells were transfected with various vectors and cultured for
48 h. Then, neurite extension was induced by DMEM with 1% horse
serum, 0.5% FBS and 100 ng/ml NGF for 48 to 72 h. Cells were ﬁxed
and stained as described. Images were obtained using a confocal micro-
scope. Morphometric measurements were performed using ImagePro
PLUS software (Media Cybernetics, Silver Spring, MD, USA). For quanti-
ﬁcation of neurite bearing cells, 100–150 cells were randomly chosen
and length of processes was measured. Cells with a process longer
than one cell diameter were deﬁned as neurite-bearing cells. Statistical
analyses were performed by the Student's t-test.
2.7. Immunoprecipitation
Immunoprecipitation was done as previously described [24]. Brieﬂy,
cells expressing tagged proteinswere harvestedwith immunoprecipita-
tion (IP) buffer containing 50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1%
NP-40, 1 mM Na3VO4 and protease inhibitor cocktail (Nacalai Tesque).
Insoluble material was removed by centrifugation at 4 °C for 10 min at
10,000 ×g and the resultant supernatants were subjected to immuno-
precipitation using indicated antibody and proteinA-sepharose beads.
After washing the beads with IP buffer, the precipitates were subjected
to SDS-PAGE followed by western blotting. Immunoreactive bands
were visualized as described [25]. In the experiment of the binding of
MAGI-1 and Shc, we used IP buffer without NaCl. To determine the
complex formation in PC12 cells, cells were lysed in a buffer consisting
of Tris–buffered saline (pH 8.0) with 0.1% Triton X-100, 60 mM
octylglucoside, 1 mM Na3VO4 and protease inhibitor cocktail.
2.8. In vitro binding assay
Full length MAGI-1 was constructed into pMal vector. The fusion
protein was then puriﬁed by one-step afﬁnity puriﬁcation speciﬁc for
maltose-binding protein (MBP) according to the manufacturer's in-
struction. GST-fused proteins were immobilized on to glutathione–
sepharose 4B (GE Healthcare Bioscience) and incubated with MBP or
MBP-fused MAGI-1 in IP buffer for 1 h at 4 °C. The beads were then
washed with IP buffer and bound proteins were analyzed by western
blotting.
2.9. Analyses of ERK and Shc activation
PC12 cells were transfected with GFP-ERK or GFP-Shc in the
presence or absence of a MAGI-1 knockdown vector and cultured for
48 h. Cells were then serum-starved for 24 h and stimulated by
100 ng/ml NGF for the indicated time periods. Cells were ﬁxed with
10% trichloroacetic acid, washed with PBS, suspended in lysis buffer
(50 mM Tris–HCl buffer, pH 7.5, containing 0.1 M NaF, 5 mM EDTA,
2% SDS and protease inhibitor) and centrifuged at 10,000 ×g for
10 min. Cleared supernatants were subjected to SDS-PAGE followed
by western blot analyses using anti-phospho p44/p42 MAP kinase,
anti-phospho Shc or anti-GFP. Relative intensities of bands were quan-
tiﬁed using ImagePro PLUS software. Statistical analyses were per-
formed by the Student's t-test.
3. Results
3.1. Knockdown of MAGI-1 caused the suppression of NGF-induced
neurite outgrowth in PC12 cells
Based on our pervious study [11], we explored possible role of
MAGI-1 in neurite extension. Effect of MAGI-1 knockdown on the
NGF-induced neurite extension was examined in PC12 rat pheochro-
mocytoma cells since this cell line is widely used to study the mecha-
nism of neurite extension [26]. We constructed two RNAi vectors,
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MAGI-1 and estimated the knockdown efﬁciency to exogenously ex-
pressed mouse MAGI-1 in COS7 cells because these target sequences
were conserved in both species. As shown in Fig. 1A, expression of
GFP-MAGI-1 was reduced by these RNAi vectors. We next generated
RNAi-resistant versions of MAGI-1, pEGFP-MAGI#1mt and -MAGI#2mt,
that harbor silent mutations within the sequences targeted by pSUPER-
MAGI-1#1 and #2, respectively. Western blot analyses conﬁrmed the
resistance of MAGI#1mt and MAGI#2mt to pSUPER-MAGI-1#1 and #2,
respectively (Fig. 1A).
Then we tried to conﬁrm the effect of these RNAi vectors against
endogenous MAGI-1 in PC12 cells. We however could not observe theFig. 1. Knockdown or overexpression of MAGI-1 caused inhibition of NGF-dependent ne
pEGFP-MAGI#1mt, pEGFP-MAGI#2mt, pSUPER (shCont), pSUPER-MAGI#1 (shMAGI#1) or p
and the lysates (10 μg of protein) were subjected to western blotting using anti-GFP. The ex
transfected with control pSUPER-GFP, pSUPER-GFP-MAGI#1 (shMAGI#1) or -MAGI#2 (shM
clonal anti-MAGI-1. (C) PC12 cells were transfected with pSUPER-GFP vector (left panel), p
medium was changed to NGF-containing serum reduced medium and cultured for addit
neurite-bearing cells in (C) was calculated and graphed. **p b 0.01. (E) PC12 cells were tra
done as in (C). (F) The percentage of neurite-bearing cells in (E) was calculated and graphsigniﬁcant reduction of endogenous MAGI-1 in western blotting, proba-
bly due to the low transfection efﬁciency; when PC12 cells were
transfected with pSUPER-GFP vector, the efﬁciency was ~10% based on
GFP detection in immunoﬂuorescence (data not shown). We thus
performed immunoﬂuorescence analyses, and knockdown of endoge-
nous MAGI1 was observed as shown in Fig. 1B. We next analyzed possi-
ble effect ofMAGI-1-knockdown onNGF-induced neurite extension, and
found that the extension was signiﬁcantly impaired inMAGI-1-deﬁcient
PC12 cells (Fig. 1C and D). It is notable that NGF-induced neurite exten-
sion was also impaired when MAGI-1 was overexpressed in the cell
(Fig. 1E and F). These results suggest that MAGI-1 plays pivotal roles in
NGF-stimulated neurite outgrowth in PC12 cells.urite outgrowth in PC12 cells. (A) COS7 cells were transfected with pEGFP-MAGI-1,
SUPER-MAGI#2 (shMAGI#2) in various combinations. After 48 h, cells were harvested
pression of β-tubulin was examined to conﬁrm the equal loading. (B) PC12 cells were
AGI#2). After 48 h, cells were ﬁxed and stained with monoclonal anti-GFP and poly-
SUPER-GFP-MAGI#1 (middle panel) or pSUPER-GFP-MAGI#2 (right panel). After 48 h,
ional 48 h. Then cells were ﬁxed and stained with anti-GFP. (D) The percentage of
nsfected with pEGFP vector (left panel) or pEGFP-MAGI-1 (right panel). Analyses were
ed. **p b 0.01.
2305H. Ito et al. / Biochimica et Biophysica Acta 1833 (2013) 2302–23103.2. MAGI-1 interacts with p75NTR
We tried to identify possible MAGI-1-interacting partner(s) involved
in NGF-mediated signaling pathway in PC12 cells. NGF is known to bind
with high afﬁnity receptor, TrkA, and low afﬁnity receptor, p75NTR [12].
Through amino acid sequence analyses of TrkA and p75NTR using NCBI
database, we found that p75NTR (NCBI accession no. NM_012610) con-
tains a putative carboxyl-terminal type 1 PDZ binding (TSPV) motif [27].
In fact, the interaction of p75NTR and another PDZ protein, Par-3, has
been reported [28]. Since MAGI-1 contains multiple PDZ domains
known to mediate interaction with several molecules, we assumed that
MAGI-1 interacts with p75NTR and thus tested the possibility. COS7
cells were transfected with GFP-p75NTR with or without myc-MAGI-1
and immunoprecipitation was carried out using anti-MAGI-1. As
shown in Fig. 2A, complex formation of MAGI-1 with p75NTR wasFig. 2. MAGI-1 interacts with p75NTR. (A) COS7 cells were transfected with pEGFP-p75NT
lysates were subjected to immunoprecipitation using anti-MAGI1/2/3. Western blotting o
(B) PC12 cells were serum starved for 6 h and then stimulated with 100 ng/ml NGF for 10
with polyclonal anti-p75. Precipitated materials (IP) and lysates (Input) were analyzed by
transfected with GFP-p75NTR together with various myc-tagged MAGI-1 fragments. Cell l
(IP) and lysates (Input) were subjected to SDS-PAGE followed by western blotting using an
of GFP-p75NTR or -p75NTRΔSPV lacking C-terminal three amino acids. Cell lysates were subj
(Input) were subjected to western blotting using anti-GFP or anti-myc. (E) In vitro binding as
GST (100 pmol) or GST-p75NTR intracellular domain (ICD) (100 pmol) conjugated glutathio
SDS-PAGE followed by western blotting using anti-MBP or anti-GST.observed. This interaction is likely to be speciﬁc since MAGI-2 and
MAGI-3 did not bind with p75NTR under the conditions (Fig. 2A).
Next, when we immunoprecipitated endogenous p75NTR from extract
of PC12 cells, endogenousMAGI-1was detected in precipitates (Fig. 2B),
strongly suggesting their physiological interaction. Notably, when cells
were stimulated with NGF, association between p75NTR and MAGI-1
was increased (Fig. 2B). We then did mapping analyses to determine
regions essential for the association between MAGI-1 and p75NTR.
Various myc-tagged MAGI-1 fragments were co-expressed with GFP-
p75NTR and immunoprecipitation was done using anti-GFP. As shown
in Fig. 2C, PDZ0-1 was found to interact with p75NTR while PDZ1–3
and PDZ4–5 were not. We thus concluded that N-terminal part con-
taining PDZ0, GK and WW domain is responsible for the binding
to p75NTR. We then tried to determine the region in p75NTR essen-
tial for the binding with MAGI-1. COS7 cells were transfected withR together with pRK5 vector, pRK5-myc-MAGI-1, -myc-MAGI-2 or -myc-MAGI-3. Cell
f precipitated materials (IP) and lysate (Input) was done using anti-myc or anti-GFP.
min or left untreated. Cells were then harvested and p75NTR was immunoprecipitated
western blotting with anti-MAGI-1 or monoclonal anti-p75NTR. (C) COS7 cells were
ysates were subjected to immunoprecipitation using anti-GFP. Precipitated materials
ti-GFP or anti-myc. (D) COS7 cells were transfected with myc-MAGI-1 in the presence
ected to immunoprecipitation using anti-MAGI-1. Precipitated materials (IP) and lysates
say of MAGI-1 and p75NTR. Recombinant MBP-MAGI-1 (400 pmol) was incubated with
ne sepharose beads. Then beads were washed and bounded materials were subjected to
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the C-terminal PDZ binding motif. When immunoprecipitation was
done using anti-MAGI-1, p75NTRΔSPVwas shown to have dramatically
reduced binding ability to MAGI-1 (Fig. 2D), indicating the importance
of the C-terminal SPV motif for the interaction with MAGI-1. We
next tested whether recombinant MAGI-1 directly associates with re-
combinant p75NTR or not. Since full length p75NTR was barely ex-
pressed in E. coli, we used the intracellular domain (ICD) containing
the C-terminal PDZ-binding motif. Consequently, MBP-MAGI-1 was
shown to associate with GST-p75NTR-ICD (Fig. 2E). Based on these re-
sults, we concluded that PDZ0 domain localized at N-terminus of
MAGI-1 interacts directly with the C-terminal SPV motif of p75NTR.
We determined the localization of MAGI-1 and p75NTR in PC12
cells by immunoﬂuorescence. In undifferentiated PC12 cells, MAGI-1
was distributed at cell body and cellular edges while p75NTR was
enriched at cellular edges (Fig. 3A, upper panels). When differentiated,
MAGI-1 and p75NTRwere found to be distributed at the tip of extended
neuronal process in addition to cytoplasm and cell peripheral areas
(Fig. 3A, lower panels). These results indicate that endogenous
MAGI-1 and p75NTR are, at least partly, co-localized in PC12 cells, sug-
gestive of physiological interaction of these proteins. We then looked
into the effect of MAGI-1 knockdown on p75NTR localization in PC12Fig. 3. Localization ofMAGI-1 and p75NTR inPC12 cells. (A) Cellswere cultured in thepresence
and anti-p75NTR. (B) Cells were transfected with control pSUPER-GFP or pSUPER-GFP-MAGI#cells. When MAGI-1 was silenced in the cells, and subcellular distribu-
tion of p75NTR was analyzed, signiﬁcant change was not observed
under the assay conditions (Fig. 3B).
3.3. MAGI-1 interacts with an adaptor protein Shc
p75NTR has been reported to enhance TrkA signaling through the
interactionwith an adaptor protein Shc, although it is not clearwhether
the interaction is direct or not [17]. Shc contains an N-terminal
phosphotyrosine binding (PTB) domain, a central glycine/proline-rich
(Gly/Pro) region and a C-terminal Src homology 2 (SH2) domain [29].
Since MAGI-1 contains two WW domains, which possibly interact
with proline-rich motif, we examined the interaction of MAGI-1 with
Shc by immunoprecipitation. COS7 cells were transfected with FLAG-
Shcwith orwithoutmyc-MAGI-1 and cell lysateswere subjected to im-
munoprecipitation using anti-MAGI-1. As shown in Fig. 4A,MAGI-1was
found to form an immunocomplex with Shc. The interaction of MAGI-1
with Shc was concluded as a direct binding since recombinant
MBP-MAGI-1was pulled downwithGST-Shc formed in a reconstitution
assay (Fig. 4B). We then carried out mapping analyses to determine
regions responsible for the association between MAGI-1 and Shc. To
determine region in MAGI-1 responsible for binding to Shc, various(+) or absence (−) of 100 ng/mlNGF for 72 h,ﬁxed and double-stainedwith anti-MAGI-1
1 (shMAGI#1). After 48 h, cells were ﬁxed and stained with anti-p75NTR. Bars, 10 μm.
Fig. 4. MAGI-1 interacts with Shc. (A) COS7 cells were transfected with FLAG-Shc with or without myc-MAGI-1. Cell lysates were subjected to immunoprecipitation using
anti-MAGI-1. Western blotting of precipitated materials (IP) and lysates (Input) was carried out with anti-myc or anti-FLAG. (B) In vitro binding assay of MAGI-1 and Shc. Recom-
binant MBP-MAGI-1 (200 pmol) or MBP (200 pmol) was incubated with GST-Shc (100 pmol) conjugated with glutathione sepharose beads. Then beads were washed and bound
materials were subjected to SDS-PAGE followed by western blotting with anti-MBP or anti-GST. (C) COS7 cells were transfected with FLAG-Shc together with various fragments of
GFP-MAGI-1. Cell lysates were subjected to immunoprecipitation using anti-FLAG. Precipitated materials (IP) and lysates (Input) were subjected to western blotting with anti-GFP
or anti-FLAG. (D) COS7 cells were transfected with myc-MAGI-1 together with various GFP-tagged Shc fragments. Cell lysates were subjected to immunoprecipitation using
anti-myc. Precipitated materials (IP) and lysates (Input) were subjected to western blotting with anti-myc or anti-GFP. (E) COS7 cells were transfected with myc-MAGI-1,
myc-Shc and GFP-p75NTR in various combinations. Cells were harvested and p75NTR was immunoprecipitated with polyclonal anti-p75. Precipitated materials (IP) and lysates
(Input) were subjected to western blotting with anti-GFP or anti-myc.
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immunoprecipitation was done using anti-FLAG. As shown in Fig. 4C,
PDZ4-5 in MAGI-1 was co-immunoprecipitated with Shc. Next, to
determine binding region in Shc, we transfected various GFP-tagged
Shc fragments with myc-MAGI-1 and immunoprecipitation was done
using anti-myc. Consequently, ShcPTB and ShcΔSH2 but not ShcΔPTB
were co-immunoprecipitated with MAGI-1 (Fig. 4D), indicating the
PTB region is responsible for the binding to MAGI-1. From these results,
we concluded that PDZ4-5 inMAGI-1 interacts directly with PTB region
in Shc.
Since MAGI-1 was found to interact with p75NTR and Shc, we here
asked if these three molecules form a ternary complex or not. Whenmyc-MAGI-1, myc-Shc and GFP-p75NTR were expressed in COS7 cells
and GFP-p75NTR was immunoprecipitated by anti-p75, the three
molecules were found to form a ternary complex (Fig. 4E).3.4. MAGI-1 regulates NGF-dependent phosphorylation of Shc and ERK in
PC12 cells
NGF binds to the TrkA/p75NTR receptor complex and stimulates ty-
rosine phosphorylation of Shc, although molecular mechanism of the
receptor-Shc interaction has been enigmatic. MAGI-1 interacts directly
with p75NTR and Shc, indicating that MAGI-1 functions as a linker
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MAGI-1 in NGF-stimulated signaling pathway leading to the subsequent
activation of Shc/Ras/Raf/ERK pathway. Thus, we examined the role of
MAGI-1 in the NGF-dependent activation of Shc and ERK in PC12 cells
by the use of RNAi technique. Asmentioned above, transfection efﬁcien-
cy of PC12 cells was relatively low, we could not observed the effect of
MAGI-1 knockdown on the NGF-induced activation of endogenous Shc
and ERK (data not shown). To monitor the effect of MAGI-1 silencing
on the activation of Shc and ERK, we did co-transfection of MAGI-1
knockdown vector and GFP-Shc or GFP-ERK expression vector. GFP-
Shc and GFP-ERK were distinguished from endogenous molecules by
western blotting because molecular masses of these proteins were dif-
ferent. Trancfected PC12 cells were stimulated with NGF for 5 min or
30 min and phosphorylated (activated) GFP-Shc was detected by west-
ern blotting using anti-phospho Shc.We found that the phosphorylation
was signiﬁcantly suppressed in MAGI-1-deﬁcient cells (Fig. 5A and B).
Using similar technique, we also found that knockdown of MAGI-1
caused the suppression of ERK activity after NGF treatment (Fig. 5C
and D). These results suggest that MAGI-1 is involved in the positive
regulation of NGF-stimulated Shc-ERK pathway. NGF-induced phos-
phorylation of GFP-Shc and -ERK was not completely suppressed in
the above experiments. Since MAGI-2 and MAGI-3 do not interact
with p75NTR (Fig. 2A), we assume that this residual phosphorylation
was due to the incomplete knockdown efﬁciency of the pSUPER-
MAGI-1 RNAi vector although the possibility of yet unidentiﬁed signal-
ing pathway(s) cannot be ruled out.Fig. 5.MAGI-1 is involved in the NGF-dependent signaling pathway in PC12 cells. (A) Cells w
tor (KD), cultured for 48 h and then serum-starved for 24 h. Cells were then stimulated with
SDS-PAGE followed by western blotting using anti-phospho-Shc or anti-GFP. (B) Relative
based on densitometry, and expressed as relative intensity to the band of 5 min-stimulated p
NGF stimulation (time 0) were less than detection limit, we showed data of 5 min and 30 m
shown are representatives of 3 independent experiments with similar results. *p b 0.05. (C
vector (KD), cultured for 48 h and serum-starved for 24 h. Cells were then stimulated with
blotting with anti-phospho-ERK or anti-GFP. (D) Relative levels of activated ERK in lysates
as relative intensity to the band of pSUPER transfected control cells treated with NGF for 5
resentatives of 3 independent experiments with similar results. *p b 0.05, **p b 0.01.4. Discussion
Biological information of individual MAGI family proteins has been
limited because of their structural similarities. We have recently devel-
oped the antibody that selectively detect MAGI-1 protein and found
that MAGI-1 was enriched in rat nervous tissues [11]. Histological study
of rat tissues revealed abundant expression of MAGI-1 in glomeruli of
adult olfactory bulb and embryonic dorsal root entry zone in spinal cord
[11]. We also found that MAGI-1 existed in the growth cone of primary
cultured rat dorsal root ganglia cells [11]. From these results,we supposed
thatMAGI-1might play pivotal roles in neurite extension or guidance. To
ascertain this hypothesis, we did knockdown of MAGI-1 in PC12 cells, a
widely used cell line for analysis of neurite outgrowth, and found
that silencing of MAGI-1 caused inhibition of NGF-dependent neurite
extension. On the other hand, overexpression of MAGI-1 also inhibited
NGF-mediated neurite extension. This may be the reason that we could
not obtain statistically clear results in the rescue experiments; it may be
difﬁcult to express proper amount of RNAi-resistant MAGI-1 which ex-
actly compensates the RNAi-mediated loss of endogenous MAGI-1. We
consider that this is the ﬁrst report describing the function ofMAGI-1 in
neural development.
Trk and p75NTR synergistically affect the downstream signaling
cascades that lead to the neurite extension [12]. It has been reported
that p75NTR speciﬁcally enhanced phosphorylation of Shc during
NGF-induced TrkA activation but the mode of interaction between
TrkA/p75NTR and Shc has not been clariﬁed [17]. In this study, weere transfected with GFP-Shc in the presence of control (C) or pSUPER-MAGI-1#1 vec-
100 ng/ml NGF for indicated time and harvested. Whole cell lysates were subjected to
levels of phosphorylated Shc in lysates were quantiﬁed with ImagePro PLUS software
SUPER transfected control cells. Because band intensities of phosphorylated Shc before
in-stimulated cells. Each bar shows the mean ± SD of results from 4 dishes. The data
) Cells were transfected with GFP-ERK together with control (C) or pSUPER-MAGI-1#1
100 ng/ml NGF for indicated time and harvested. Lysates were subjected to western
were calculated with ImagePro PLUS software based on densitometry, and expressed
min. Each bar shows the mean ± SD of results from 4 dishes. The data shown are rep-
2309H. Ito et al. / Biochimica et Biophysica Acta 1833 (2013) 2302–2310found that MAGI-1 interacted directly with not only p75NTR but also
Shc, both of which are principal components in NGF-mediated signal-
ing. Frommapping analysis, p75NTR and Shc bind different regions in
MAGI-1 molecule, supporting the notion that these three proteins
may form a ternary complex.
We have hypothesized thatWWdomain inMAGI-1 could form com-
plex with glycine/proline-rich domain in Shc. Contrary to our assump-
tion, PDZ4–5 region in MAGI-1 could interact with PTB region in Shc.
PTB domain is known to interact with NPX(p)Y-like motif (where pY
is phosphotyrosine) [30]. We tried to ﬁnd NPX(p)Y-like motif in
PDZ4–5 region in MAGI-1 using GPS2.1, a software that predict kinase-
speciﬁc phosphorylation site. However, we could not ﬁnd the PTB bind-
ing motif in that region (data not shown). Recently, Chen et al. reported
that a PTB domain containing protein tensin2 could interact with delet-
ed in liver cancer 1 (DLC1), which does not have NPX(p)Y-likemotif and
proposed a novel binding mode of PTB domain [31]. Such a novel bind-
ing mechanism may be involved in the interaction of MAGI-1 with Shc
although additional extensive experiments are required to understand
the binding mode of these molecules.
In PC12 cells, NGF induces transient (b5 min) and sustained
(>30 min) activation of ERK and the latter is considered to play an es-
sential role for neurite extension [32]. There are several ERK activating
pathways that lead to the neurite extension. NGF-induced activation
of FRS2/Crk/C3G/Rap1/B-Raf pathway mediated the sustained activa-
tion of ERK [32]. In contrast, other group has reported that a very little
contribution of NGF-induced Rap1 activation on ERK activity [33]. Reg-
ulators of G-protein signaling (RGS) 12 has been reported to act as a
Ras/B-Raf/MEK scaffold and play a critical role in NGF-mediated differ-
entiation [34]. Dual-speciﬁcity tyrosine-phosphorylated and regulated
kinase 1A (DYRK1A) facilitates the formation of a Ras/B-Raf/MEK-1
complex and upregulates ERK activation [35]. In this study, we showed
that NGF-induced transient and sustained activation of Shc and ERKFig. 6. Hypothetical model of MAGI-1-mediated NGF signaling. MAGI-1 localizes at juxtamem
by NGF, MAGI-1 may control the phosphorylation of Shc by TrkA and regulate the subsequwere suppressed by MAGI-1 silencing. Together with the results that
p75NTR binds speciﬁcally with MAGI-1 but not MAGI-2 and MAGI-3,
MAGI-1 is suggested to regulate neurite outgrowth through linking
p75NTR and Shc-ERK pathway (Fig. 6). However, the possibility cannot
be ruled out that residual phosphorylation of Shc and ERK observed in
NGF-treated MAGI-1-deﬁcient PC-12 cells (Fig. 5) is mediated by yet
unidentiﬁed molecule(s).
The four neurotrophins are known to interact speciﬁcally with three
members of Trk receptors, TrkA, TrkB and TrkC. NGF interactswith TrkA.
While BDNF and NT-4 interact with TrkB, NT-3 interacts with TrkC. On
the other hand, the neurotrophins interact with p75NTR with similar
afﬁnity [12]. We found the interaction of MAGI-1 and p75NTR that
resulted to control NGF-dependent signaling pathway. It is susceptible
that MAGI-1 may control the signaling pathway activated by all four
neurotrophins.
Recently, genetic associations of MAGI-1 and psychiatric disorder
such as bipolar disorder and schizophrenia have been reported [36,37].
The missense mutation of p75NTR (S205L) has been shown to be asso-
ciated with depressive disorder and suicidal behavior [38]. The roles of
neurotrophins on the neuronal development such as neurite outgrowth
and synaptogenesis have been investigated extensively [14,39]. Neuro-
developmental theory of mental illness such as schizophrenia is widely
accepted [40]. Regulation of the neurotrophin signaling by MAGI-1 may
contribute to the pathogenesis of mental illness. Further analysis of
MAGI-1 in neuronal signaling may lead to the understanding of the eti-
ology of psychiatric disorders.
5. Conclusion
MAGI-1 interacts with p75NTR and Shc, controls NGF-stimulated
activation of the Shc-ERK pathway and regulates neurite extension
of PC12 cells.brane region in PC12 cells and acts as a scaffold for p75NTR and Shc. Upon stimulation
ent signaling pathway that induces neurite outgrowth.
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